980 resultados para Albacete, Joan Manel -- Intervius


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Relevância:

20.00% 20.00%

Publicador:

Relevância:

20.00% 20.00%

Publicador:

Resumo:

opera et studio Joan. Henrici Zopfii

Relevância:

20.00% 20.00%

Publicador:

Resumo:

OBJECTIVES The aim of this study was to compare the efficacy of amphilimus-eluting stents (AES) with that of everolimus-eluting stents (EES) in patients with diabetes mellitus (DM). BACKGROUND The AES is a polymer-free drug-eluting stent that elutes sirolimus formulated with an amphiphilic carrier from laser-dug wells. This technology could be associated with a high efficacy in patients with DM. METHODS This was a multicenter, randomized, noninferiority trial. Patients with DM medically treated with oral glucose-lowering agents or insulin and de novo coronary lesions were randomized in a 1:1 fashion to AES or EES. The primary endpoint was the neointimal (NI) volume obstruction assessed by optical coherence tomography at 9-month follow-up. RESULTS A total of 116 lesions in 112 patients were randomized. Overall, 40% were insulin-treated patients, with a median HbA1c of 7.3% (interquartile range: 6.7% to 8.0%). The primary endpoint, NI volume obstruction, was 11.97 ± 5.94% for AES versus 16.11 ± 18.18% for EES, meeting the noninferiority criteria (p = 0.0003). Pre-specified subgroup analyses showed a significant interaction between stent type and glycemic control (p = 0.02), with a significant reduction in NI hyperplasia in the AES group in patients with the higher HbA1c (p = 0.03). By quantitative coronary angiography, in-stent late loss was 0.14 ± 0.24 for AES versus 0.24 ± 0.57 mm for EES (p = 0.27), with a larger minimal lumen diameter at follow-up for AES (p = 0.02), mainly driven by 2 cases of occlusive restenosis in the EES group. CONCLUSIONS AES are noninferior to EES for the coronary revascularization of patients with DM. These results suggest a high efficacy of the AES and may support the potential benefit of this stent in patients with DM. (A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus [RESERVOIR]; NCT01710748).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Signatur des Originals: S 36/F05334

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Signatur des Originals: S 36/F05335

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Signatur des Originals: S 36/F09498

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Este artículo se propone analizar la noción de experiencia presente en la obra de la historiadora feminista norteamericana Joan W. Scott. Se realiza un recorrido por las conceptualizaciones de dicha noción utilizadas en la Historia Social de los años sesenta, setenta y ochenta con las cuales Scott ha tenido importantes diálogos y discusiones. Por último, se presentan algunas críticas y limitaciones que, tanto desde la historia con perspectiva de género como desde la teoría feminista, se han señalado sobre el concepto de experiencia desarrollada por Scott